1. Liver fibrosis markers as assessed by ultrasound elastography and serum samples: A large comparative study in hepatitis virus B and C liver diseases
- Author
-
Tomoyuki Takashima, Hiroki Nishikawa, Yoshiyuki Sakai, Chikage Nakano, Nobuhiro Aizawa, Kunihiro Hasegawa, Seiichi Hirota, Takashi Nishimura, Reiichiro Kondo, Ryo Takata, Yoshinori Iwata, Jiro Fujimoto, Kazunori Yoh, Tomoko Aoki, Hirohisa Yano, Hiroko Iijima, Masayoshi Kage, Hirayuki Enomoto, Noriko Ishii, Shuhei Nishiguchi, Naoto Ikeda, and Yukihisa Yuri
- Subjects
Hepatitis virus ,medicine.medical_specialty ,Hepatology ,business.industry ,Liver fibrosis ,Serum samples ,Gastroenterology ,03 medical and health sciences ,0302 clinical medicine ,Infectious Diseases ,Chronic hepatitis ,Collagen fiber ,030220 oncology & carcinogenesis ,Internal medicine ,Cohort ,medicine ,Ultrasound elastography ,030211 gastroenterology & hepatology ,business ,Pathological - Abstract
AIM We aimed to compare the well-established liver fibrosis (LF) markers in Japanese patients with chronic hepatitis B (CHB, n = 331) and chronic hepatitis C (CHC, n = 886) and to discuss possible causes of differences in results between CHB patients and CHC patients. METHODS Virtual touch quantification (VTQ) in acoustic radiation force impulse, Fibrosis-4 (Fib-4) index, aspartate aminotransferase to platelet ratio index (APRI), and hyaluronic acid (HA) were compared between the two cohorts. As an additional investigation, total collagen proportional area (TCPA, %) was tested using liver pathological samples (n = 83). RESULTS Significant LF (F2 or greater) and advanced LF (F3 or greater) were identified in 153 (46.2%) and 76 (23.0%) patients in the CHB cohort and 579 (65.3%) and 396 (44.7%) patients in the CHC cohort. The median VTQ, Fib-4 index, APRI, and HA values in the CHB cohort were 1.20 m/s, 1.36, 0.44, and 25 ng/mL; those in the CHC cohort were 1.32 m/s, 2.60, 0.74, and 65.5 ng/mL (P-values, all
- Published
- 2019